- Home
- BTBT vs FHTX Comparison
BTBT vs FHTX Comparison
Compare BTBT & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BTBT | FHTX |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 569.7M | 332.2M |
| IPO Year | 2017 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BTBT | FHTX |
|---|---|---|
| Price | $1.63 | $5.01 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | $7.00 | ★ $11.50 |
| AVG Volume (30 Days) | ★ 19.0M | 133.7K |
| Earning Date | 01-01-0001 | 06-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 218.75 | 25.32 |
| EPS | ★ 0.46 | N/A |
| Revenue | ★ $108,050,720.00 | $30,909,000.00 |
| Revenue This Year | $7.15 | $14.62 |
| Revenue Next Year | $90.95 | $15.27 |
| P/E Ratio | $3.52 | ★ N/A |
| Revenue Growth | ★ 140.56 | 36.75 |
| 52 Week Low | $1.49 | $2.94 |
| 52 Week High | $4.55 | $6.95 |
Technical Indicators
Market Signals| Indicator | BTBT | FHTX |
|---|---|---|
| Relative Strength Index (RSI) | 44.84 | 38.75 |
| Support Level | $1.53 | $4.44 |
| Resistance Level | $2.43 | $5.85 |
| Average True Range (ATR) | 0.11 | 0.37 |
| MACD | 0.01 | -0.09 |
| Stochastic Oscillator | 25.00 | 28.94 |
Price Performance
Historical ComparisonAbout BTBT Bit Digital Inc.
Bit Digital Inc is engaged in the Bitcoin mining business, Ethereum staking activities and specialized cloud-infrastructure services for artificial intelligence applications through its wholly owned subsidiaries. Its mining platform operates with the primary intent of accumulating bitcoin which may sell for fiat currency from time to time depending on market conditions. The Company has four reportable segments: digital asset mining, cloud services, colocation services, and ETH Staking. It generates majority of its revenue from digital asset mining.
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.